Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CCCTC-binding factor (CTCF), an 11-zinc-finger factor involved in gene regulation, utilizes different zinc fingers to bind varying DNA target sites. Additionally we are shipping CTCFL Proteins (11) and CTCFL Kits (7) and many more products for this protein.
Showing 10 out of 76 products:
Human Polyclonal CTCFL Primary Antibody for ICC, IF - ABIN4285064
Hines, Bazarov, Mukhopadhyay, Yaswen: BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas. in PLoS ONE 2010
Show all 3 references for 4285064
Human Polyclonal CTCFL Primary Antibody for ELISA, WB - ABIN151496
Klenova, Morse, Ohlsson, Lobanenkov: The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. in Seminars in cancer biology 2002
Show all 2 references for 151496
Human Polyclonal CTCFL Primary Antibody for ELISA, WB - ABIN129668
Dougherty, Ichim, Liu, Reznik, Min, Ghochikyan, Agadjanyan, Reznik: Selective apoptosis of breast cancer cells by siRNA targeting of BORIS. in Biochemical and biophysical research communications 2008
Show all 2 references for 129668
Human Polyclonal CTCFL Primary Antibody for WB - ABIN2775056
Hong, Kang, Abdullaev, Flanagan, Pack, Fischette, Adnani, Loukinov, Vatolin, Risinger, Custer, Chen, Zhao, Nguyen, Barrett, Lobanenkov, Schrump: Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. in Cancer research 2005
BORIS is associated with the cancer stem cell-like traits of human liver cancer cells through the epigenetic regulation of OCT4 (show POU5F1 Antibodies).
In this study, the methylation status of BORIS was tested by methylation specific polymerase chain reaction in human hepatocarcinoma (HCC (show FAM126A Antibodies)) cell lines and 43 pairs of tissue specimens. Frequently demethylation of BORIS in HCC (show FAM126A Antibodies) was significantly higher than that in the paired adjacent non-tumor tissues (P=0.019), and it was correlated with tumor size (P=0.025) and clinical TNM (show ODZ1 Antibodies) stage (P=0.035).
Effectively controlling BORIS/CTCFL levels can inhibit disease establishment and hence can be considered as a potent target for cancer therapy
BORIS is associated with cancer stem cell-enriched populations of several epithelial tumor cells and the different phenotypes depend on the origin of tumor cells.
Data found that BORIS and CTCF (show CTCF Antibodies) expression in low-grade squamous intraepithelial lesions and invasive cervical carcinoma is higher than in normal samples. The possible utility of BORIS and CTCF (show CTCF Antibodies) as biomarkers in cervical neoplasm requires further analysis.
In the first detailed analysis in cancer, a marked loss of CHD8 (show CHD8 Antibodies) expression and increased BORIS/CTCF (show CTCF Antibodies) ratio indicate frequent disruption of CTCF (show CTCF Antibodies) and its effector genes in PCa (show FLVCR1 Antibodies).
Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.
High BORIS transcript variants are associated with laryngeal squamous cell carcinomas.
CTCFL/BORIS was amongst the top ranked genes differentially expressed between endometrioid and non-endometrioid tumors, and increasing mRNA level of CTCFL/BORIS was highly significantly associated with poor survival.
The serum levels of MAGE (show MAGEB10 Antibodies)-A and BORIS mRNA, as well as let-7b were significantly higher in patients.
The TGFB (show TGFB1 Antibodies) pathway as most affected by embryonic Ctcfl expression.
down-regulation of endogenous BORIS by specific shRNAs inhibited both RNA transcription and cell cycle progression. The results altogether suggest a role for BORIS in coordinating S phase events with mitosis.
Rb2 (show RBL2 Antibodies) coimmunolocalizes with the chromatin insulator CCCTC-binding factor (CTCF (show CTCF Antibodies)) and BORIS in T-antigen-positive but not in T-antigen-negative cells.
These findings show that BORIS expression is more widespread than previously believed, and suggest a role for BORIS in nucleolar function.
findings indicate that BORIS-induced expression of TSP50 (show PRSS50 Antibodies) is governed by accessibility and binding of BORIS to the promoter
These findings define transcriptional regulation of CST (Gal3st1 (show GAL3ST1 Antibodies)) expression as a critical role for BORIS in spermatogenesis.
CTCFL and PRMT7 (show PRMT7 Antibodies) may play a role in male germline imprinted gene methylation.
CTCFL/BORIS is a methylation-independent DNA-binding protein (show HSF4 Antibodies) that preferentially binds to the paternal H19 (show NCKAP1 Antibodies) differentially methylated region
DNA damage-induced and ATR (show ATR Antibodies)/Rfx1 (show RFX1 Antibodies)-mediated increase of miR (show MLXIP Antibodies)-709 expression in exposed testes may be a protective mechanism that effectively decreases a cellular level of BORIS to prevent massive aberrant erasure of DNA methylation (show HELLS Antibodies) after radiation exposure.
CCCTC-binding factor (CTCF), an 11-zinc-finger factor involved in gene regulation, utilizes different zinc fingers to bind varying DNA target sites. CTCF forms methylation-sensitive insulators that regulate X-chromosome inactivation. This gene is a paralog of CTCF and appears to be expressed primarily in the cytoplasm of spermatocytes, unlike CTCF which is expressed primarily in the nucleus of somatic cells. CTCF and the protein encoded by this gene are normally expressed in a mutually exclusive pattern that correlates with resetting of methylation marks during male germ cell differentiation. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.
CCCTC-binding factor (zinc finger protein)-like
, CCCTC-binding factor-like protein
, brother of the regulator of imprinted sites
, brother of regulator of imprinted sites
, transcriptional repressor CTCFL
, transcriptional repressor CTCFL-like
, BORIS-like protein
, CTCF paralog
, CTCF-like protein
, cancer/testis antigen 27
, putative high mobility group protein 1-like 1
, putative high mobility group protein B1-like 1
, zinc finger protein CTCF-T
, Brother of the regulator of imprinted sites
, likely orthologue of H. sapiens CCCTC-binding factor-like protein (CTCFL)